Aminoglycosides are Saves as a Last Resort

878 Words2 Pages

Aminoglycosides are broad spectrum antibiotics that are most effective against aerobic gram-negative bacteria. Aminoglycosides are distinguishable by the aminocyclitol ring; which is a six membered ring with amino group substituents ("amingolycosides," ).

A highly conserved aminocyclitol ring, a central scaffold that is linked to various aminosugar moieties. The aminocyclitol ring is comprised primarily of 2-deoxystreptamine. And has 1,3-diamino functionality and three or four hydroxyl groups that provide anchoring points for aminosugar. Aminoglycosides can be divided into 3 subclasses, depending on the substitution pattern: 4-monosubsituted, or 4, 5- or 4, 6- disubstituted. Aminoglycosides in each class show close structural resemblance. Although, 2-deoxystreptamine or 2 deoxy-myo-inosa-1,3-diamine is actually derived from D-glucose-6-phosphate biosynthetically, the numbering system is based on streptamine’s biogenic precursor myo-inosa. (Chittapragada, Roberts & Ham, 2009)

There are various types of aminoglycosides currently used, the most common being; amikacin, gentamicin, tobramycin and neomycin. The mechanism of action for all aminoglycosides is by inhibiting protein synthesis in the bacterial cell by binding to ribosome 30S sub unit ("amingolycosides,”). This is accomplished by passive diffusion across the bacterial cell membrane and then active transport across the cytoplasmic membrane to bind to ribosome 30S ("amingolycosides,”). Thus, inhibiting protein synthesis by inducing a misread of the genetic code mRNA. The entire process is oxygen dependent, which is why aminoglycosides are most effective against aerobic bacteria ("amingolycosides,”).

Aminoglycosides are usually a last resort antibiotic due to th...

... middle of paper ...

...lycosideResidues.pdf

Gentocin injectable solution. (2013, May 13). Retrieved from http://www.drugs.com/vet/gentocin-injectable-solution-100-mg-can.html

Gonzalez, U., & Spencer, J. (1998). Aminoglycosides: A practical review. Retrieved from http://www.aafp.org/afp/1998/1115/p1811.html

Mingeot-Leclercq, M., & Taulkens, P. M. (1999). Aminoglycosides: Nephrotoxicity. Antimicrobial Agents and Chemotherapay, 43(5), Retrieved from http://aac.asm.org/content/43/5/1003.full

Papich, M. (n.d.). Neomycin. Retrieved from http://www.petplace.com/drug-library/neomycin/page1.aspx

Selimoglu, E. (2007). Aminoglycoside-induced ototoxicity. Current Pharmaceutical Design, 13, 119-126. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17266591

VetSuite, V. (n.d.). Tobramycin. Retrieved from http://www.wvc.vetsuite.com/Templates/ContentPages/Articles/ViewArticleContent.aspx?Id=402

Open Document